S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Anastrozole|DRUG: Everolimus|DRUG: Placebo - Anastrozole|DRUG: Placebo - Everolimus
Sponsor: SWOG Cancer Research Network
Collaborators: AstraZeneca|Novartis